share_log

Janux Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jay Lichter, Ph.D. (“Lichter”)(21.2%),Tighe Reardon (“Reardon”)(12.5%), etc.

Janux Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Jay Lichter, Ph.D. (“Lichter”)(21.2%),Tighe Reardon (“Reardon”)(12.5%)等

SEC announcement ·  2023/11/15 18:22
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息